These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 1569493)
1. Radioimmunodetection in cancer identification. Goldenberg DM; Larson SM J Nucl Med; 1992 May; 33(5):803-14. PubMed ID: 1569493 [No Abstract] [Full Text] [Related]
2. Diagnosis of colorectal and ovarian carcinoma. Application of immunoscintigraphic technology. Targeted Diagn Ther; 1992; 6():1-237. PubMed ID: 1576341 [No Abstract] [Full Text] [Related]
3. Oncoscint for detection of disseminated colorectal and ovarian cancer. Med Lett Drugs Ther; 1993 Jun; 35(898):52-3. PubMed ID: 8497207 [No Abstract] [Full Text] [Related]
4. Application of radioimmunodetection with a radiolabeled monoclonal antibody to CEA (BW 431/26) in colorectal and breast cancer. Lind P Pathol Biol (Paris); 1993 Jan; 41(1):39. PubMed ID: 8316463 [No Abstract] [Full Text] [Related]
6. [Methodology and clinical usefulness of radioimmunoimaging using radiolabeled monoclonal antibodies]. Endo K; Watanabe N Nihon Rinsho; 1996 Jun; 54(6):1604-9. PubMed ID: 8691616 [TBL] [Abstract][Full Text] [Related]
7. [A clinical evaluation of MAb BW 835/6 in breast and ovarian cancer]. Trampert L; Villena C; Benz P; Keweloh HC; Schmidt W; Oberhausen E Nuklearmedizin; 1992 Dec; 31(6):249-53. PubMed ID: 1491965 [TBL] [Abstract][Full Text] [Related]
8. Correlative imaging with monoclonal antibodies in colorectal, ovarian, and prostate cancer. Neal CE; Meis LC Semin Nucl Med; 1994 Oct; 24(4):272-85. PubMed ID: 7817200 [TBL] [Abstract][Full Text] [Related]
9. Radioimmunoscintigraphy in the management of colorectal and ovarian cancer: does identification improve outcome? Markman M Cancer Invest; 2000; 18(3):289-90. PubMed ID: 10755000 [No Abstract] [Full Text] [Related]
10. Comparison of immunoscintigraphy and computerized tomography in identifying colorectal cancer: individual lesion analysis. Corbisiero RM; Yamauchi DM; Williams LE; Esteban JM; Odom-Maryon T; Beatty JD Cancer Res; 1991 Oct; 51(20):5704-11. PubMed ID: 1913688 [TBL] [Abstract][Full Text] [Related]
11. Cancer patients benefit from monoclonal imaging. Neal CE Diagn Imaging (San Franc); 1993 Jun; 15(6):92-7. PubMed ID: 10148791 [No Abstract] [Full Text] [Related]
13. Volume rendering and bicolour scale in double isotope studies: application to immunoscintigraphy and bone landmarking. Loboguerrero A; Pérault C; Liehn JC Eur J Nucl Med; 1992; 19(3):201-4. PubMed ID: 1572385 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody imaging of colorectal and ovarian cancer. Haseman MK West J Med; 1994 Oct; 161(4):412. PubMed ID: 7817555 [No Abstract] [Full Text] [Related]
15. Nuclear medicine techniques for the study of breast cancer. Bombardieri E; Crippa F; Maffioli L; Greco M Eur J Nucl Med; 1997 Jul; 24(7):809-24. PubMed ID: 9211769 [No Abstract] [Full Text] [Related]
16. Radioimmunoscintigraphy of metastatic breast carcinoma. Taylor JL; Taylor DN; Lowry C; Keeling AA; Bradwell AR; McIntosh A; Rhodes A Eur J Surg Oncol; 1992 Feb; 18(1):57-63. PubMed ID: 1737595 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of 99mTc-anti-CEA immunoscintigraphy in patients with liver metastases from colorectal carcinoma. Bock E; Becker W; Scheele J; Wolf F Nuklearmedizin; 1992 Jun; 31(3):80-3. PubMed ID: 1641359 [TBL] [Abstract][Full Text] [Related]
19. [The value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and relapse diagnosis of colorectal tumors]. Barzen G; Zwicker C; Neumann K; Löhde E; Raakow R; Böse-Landgraf W; Richter W; Hierholzer J; Langer M; Felix R Rofo; 1992 Jan; 156(1):3-10. PubMed ID: 1733472 [TBL] [Abstract][Full Text] [Related]